CSIMarket


Sight Sciences Inc   (SGHT)
Other Ticker:  
 


 

Sight Sciences Inc

SGHT's Financial Statements and Analysis



Sight Sciences Inc narrowed third quarter of 2023 net loss per share of $-0.27 compare to net loss per share of $-0.46 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.30 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -0.27 $  19 Mill
$+0.19     $+1M     +3.51 %



Sight Sciences Inc 's Revenue rose by 3.51 % in third quarter of 2023 (Sep 30 2023) year on year, to $19 million and declined by -16.28 % sequentially.


Sight Sciences Inc is

More on SGHT's Income Statement



Sight Sciences Inc in the third quarter of 2023 recorded net loss of $-13.035 million, an improvement compare to net loss of $-22.229 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-14.754 million realized in previous quarter.

More on SGHT's Growth

Sight Sciences Inc Inventories
Inventories grew by 67.39 % to $9 million from III. Quarter a year ago, sequentially inventories rose by 16.86 %. In Sep 30 2023 company's net cash and cash equivalents decreased by $-10 million, capital expenditures fell by -0.27211.76%, to $0 millions compare to same quarter a year ago

More on SGHT's Cash flow Statement


Sight Sciences Inc does not pay out common stock dividend.

In trailing twelve-month period Sight Sciences Inc payed $ -1.15 cash per share, on a free-cash flow basis .

Book value fell by -6.92 % sequentially to $2.61 per share, -15.89% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 2.61 per share from $ 2.80.

Company issued 0.13 million shares or 0.28 % in Sep 30 2023.


More on SGHT's Dividends

 Market Capitalization (Millions) 332
 Shares Outstanding (Millions) 49
 Total Debt (Millions $) 34
 Revenue (TTM) (Millions $) 82
 Net Income (TTM) (Millions $) -62
 Cash Flow (TTM) (Millions $) -55
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Sight Sciences Inc does not pay out common stock dividend.

In trailing twelve-month period Sight Sciences Inc had negative $ -1.15 cash flow per share, on a free-cash flow basis .

Book value fell by -6.92 % sequentially to $2.61 per share, -15.89% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 2.61 per share from $ 2.80.

Company issued 0.13 million shares or 0.28 % in Sep 30 2023.


More on SGHT's Balance Sheets

 Market Capitalization (Millions) 332
 Shares Outstanding (Millions) 49
 Total Debt (Millions $) 34
 Revenue (TTM) (Millions $) 82
 Net Income (TTM) (Millions $) -62
 Cash Flow (TTM) (Millions $) -55
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Sight Sciences Inc Earnings

Sight Sciences Inc's Future Shines Bright as Investors Thrive on Promising Results

Investors Optimistic About Sight Sciences Inc's Future Performance
Sight Sciences Inc, a leading medical equipment and supplies company, has shown promising results in the third quarter of 2023, with a decrease in loss per share and an improvement in earnings per share compared to the previous year. While the revenue increased slightly by 3.507% to $19.33 million from $18.68 million in the same reporting period a year ago, it fell sequentially by -16.275% from $23.09 million.
Despite the revenue gain lagging behind contemporaries in the Medical Equipment and Supplies sector, Sight Sciences Inc experienced a 4.03% improvement in revenue compared to the third quarter of 2022. These results indicate a p...

Sight Sciences Inc.'s Remarkable 2Q 2023: Substantial Revenue Growth and Shrinking Losses Set New Standard in Medical Equipment Industry

Sight Sciences Inc, a medical equipment and supplies company, has shown impressive performance in the second quarter of 2023 when compared to the same period last year. The company managed to decrease its loss per share from $-0.50 to $-0.30, indicating improved financial health. Additionally, the earnings per share (EPS) improved from $-0.35 in the previous quarter, further demonstrating the company's positive momentum.
One of the key highlights of Sight Sciences Inc's second quarter performance is its revenue growth. The company experienced a significant jump of 34.018%, with revenue reaching $23.09 million compared to $17.23 million in the same quarter last year. In comparison to the previous quarter,...

Sight Sciences Inc Struggles to Achieve Profitability Despite Impressive Revenue Surge in First Quarter of 2023

The stock market can be a tricky place to navigate, and when it comes to investing in companies, it is essential to conduct thorough research before making any decisions. One company that has recently made headlines in the stock market is Sight Sciences Inc.
According to recent financial reports, Sight Sciences Inc recorded a cumulative net loss of $-80 million during the 12 months ending in the first quarter of 2023, resulting in a negative return on equity (ROE) of -47.71%. This ROE is lower than 50 other companies within the Medical Equipment and Supplies industry, indicating that there may be better investment opportunities ava...


Date modified: 2023-11-08T18:28:58+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com